Joseph L. Goldstein, Director at REGENERON PHARMACEUTICALS INC (REGN), sold 4,000 shares at $360.00 ($1.5M) on 2018-07-05, disclosed to the SEC on 2018-07-09.
Open-market sale of $1.5M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $360.00 | 2,000 | $720K | 49.3% |
| 2 | $370.00 | 2,000 | $740K | 50.7% |
| Total | $365.00 avg | 4,000 | $1.5M | 100% |
| Filing → |
| REGN | SELL | 2022-04-01 | $1.7M | — | Filing → |
| REGN | SELL | 2021-09-13 | $1.6M | — | Filing → |
| REGN | SELL | 2021-06-08 | $1.0M | — | Filing → |